» Articles » PMID: 35311986

Perceptions of the Health Risks of Cannabis: Estimates from National Surveys in Canada and the United States, 2018-2019

Overview
Journal Health Educ Res
Specialty Medical Education
Date 2022 Mar 21
PMID 35311986
Authors
Affiliations
Soon will be listed here.
Abstract

Few studies have compared knowledge of the specific health risks of cannabis across jurisdictions. This study aimed to examine perceptions of the health risks of cannabis in Canada and US states with and without legal non-medical cannabis. Cross-sectional data were collected from the 2018 and 2019 International Cannabis Policy Study online surveys. Respondents aged 16-65 (n = 72 459) were recruited from Nielsen panels using non-probability methods. Respondents completed questions on nine health effects of cannabis (including two 'false' control items). Socio-demographic data were collected. Regression models tested differences in outcomes between jurisdictions and by frequency of cannabis use, adjusting for socio-demographic factors. Across jurisdictions, agreement with statements on the health risks of cannabis was highest for questions on driving after cannabis use (66-80%), use during pregnancy/breastfeeding (61-71%) and addiction (51-62%) and lowest for risk of psychosis and schizophrenia (23-37%). Additionally, 12-18% and 6-7% of respondents agreed with the 'false' assertions that cannabis could cure/prevent cancer and cause diabetes, respectively. Health knowledge was highest among Canadian respondents, followed by US states that had legalized non-medical cannabis and lowest in states that had not legalized non-medical cannabis (P < 0.001). Overall, the findings demonstrate a substantial deficit in knowledge of the health risks of cannabis, particularly among frequent consumers.

Citing Articles

How are pro- and anti-cannabis messaging exposures related to US young adult cannabis use-related factors?.

Cui Y, LoParco C, Romm K, Cavazos-Rehg P, Yang Y, McCready D Health Educ Res. 2024; 40(1).

PMID: 39658260 PMC: 11840750. DOI: 10.1093/her/cyae038.


Prevalence of Cannabis Use Among US Workers in 15 States, 2016-2020.

Evoy R, Victoroff T Am J Public Health. 2024; 114(S8):S645-S653.

PMID: 39442027 PMC: 11499688. DOI: 10.2105/AJPH.2024.307788.


Regular cannabis use modulates gamma activity in brain regions serving motor control.

Webert L, Schantell M, John J, Coutant A, Okelberry H, Horne L J Psychopharmacol. 2024; 38(11):949-960.

PMID: 39140179 PMC: 11524774. DOI: 10.1177/02698811241268876.


A systematic review of cannabis health warning research.

Massey Z, Hammond D, Froeliger B Prev Med Rep. 2024; 37:102573.

PMID: 38222305 PMC: 10787239. DOI: 10.1016/j.pmedr.2023.102573.


Cannabis Use Frequency and Cannabis-Related Consequences in High-Risk Young Adults Across Cannabis Legalization.

Doggett A, Belisario K, McDonald A, Ferro M, Murphy J, MacKillop J JAMA Netw Open. 2023; 6(9):e2336035.

PMID: 37755827 PMC: 10534274. DOI: 10.1001/jamanetworkopen.2023.36035.


References
1.
Compton W, Han B, Jones C, Blanco C, Hughes A . Marijuana use and use disorders in adults in the USA, 2002-14: analysis of annual cross-sectional surveys. Lancet Psychiatry. 2016; 3(10):954-964. DOI: 10.1016/S2215-0366(16)30208-5. View

2.
Fotuhi O, Fong G, Zanna M, Borland R, Yong H, Cummings K . Patterns of cognitive dissonance-reducing beliefs among smokers: a longitudinal analysis from the International Tobacco Control (ITC) Four Country Survey. Tob Control. 2012; 22(1):52-8. PMC: 4009366. DOI: 10.1136/tobaccocontrol-2011-050139. View

3.
Brooks-Russell A, Ma M, Levinson A, Kattari L, Kirchner T, Anderson Goodell E . Adolescent Marijuana Use, Marijuana-Related Perceptions, and Use of Other Substances Before and After Initiation of Retail Marijuana Sales in Colorado (2013-2015). Prev Sci. 2018; 20(2):185-193. PMC: 8086773. DOI: 10.1007/s11121-018-0933-2. View

4.
Moss H, Chen C, Yi H . Measures of substance consumption among substance users, DSM-IV abusers, and those with DSM-IV dependence disorders in a nationally representative sample. J Stud Alcohol Drugs. 2012; 73(5):820-8. PMC: 3410949. DOI: 10.15288/jsad.2012.73.820. View

5.
Fischer B, Imtiaz S, Rudzinski K, Rehm J . Crude estimates of cannabis-attributable mortality and morbidity in Canada-implications for public health focused intervention priorities. J Public Health (Oxf). 2015; 38(1):183-8. PMC: 4750519. DOI: 10.1093/pubmed/fdv005. View